PoreWise

One finding · Human trial · 2023

Study title

Efficacy of anti-sebum moisturizing cream containing 2% l-carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial

Kind of evidence
Human trial 2023 · 90 people · subjects with seborrhea · PMID 37194909
Measured outcome
Skin effect
Year
2023
Who was studied
90 subjects with seborrhea
Sample size
90
Measured outcome
In 90 people with seborrhea, moisturisers containing 2% L-carnitine, 5% epigallocatechin gallate, or both produced statistically significant reductions in sebum level from baseline over 4 weeks, with the EGCG and combination groups showing greater anti-sebum effects than L-carnitine alone (p = 0.009).
Certainty
Moderate
Who was measured
People with seborrhea applying an anti-sebum moisturising cream for 4 weeks.
Study limits
All three arms contained active ingredients; sebum was measured alongside hydration and TEWL improvements.

Where it comes from

PMID 37194909

Skin concerns studied

Other findings on the same ingredient or concern

  1. Skin effect
    Effects of a grapeseed oil (Vitis vinifera L.) loaded dermocosmetic nanoemulgel on biophysical parameters of facial skin: A split-face, blinded, placebo-controlled study

    In a split-face, blinded, placebo-controlled study of 15 volunteers, a grapeseed-oil nanoemulgel applied for 12 weeks significantly reduced facial sebum production and fine and large pores while significantly increasing skin moisture content and elasticity versus placebo (all p<0.05).

    Human trial · 2022 · 15 people · healthy volunteers · Facial sebum, pore appearance, skin moisture and elasticity over 12 weeks. · Very small sample; measurements were taken on the cheeks/half-face.

    PMID 35713012

  2. Skin effect
    The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content

    In a 12-week single-blind, base-controlled study in healthy men, a cream containing 3% Cannabis seed extract significantly reduced cheek sebum and erythema compared with the extract-free base (p<0.05).

    Human trial · 2015 · Healthy men · Cheek sebum (Sebumeter) and erythema (Mexameter) over 12 weeks. · The study is single-blind comparative.

    PMID 26142529

  3. Skin effect
    The effect of 2% niacinamide on facial sebum production

    In a double-blind, placebo-controlled trial of 100 Japanese subjects, a 2% niacinamide moisturiser significantly lowered sebum excretion rate after 2 and 4 weeks; in a separate 30-person Caucasian split-face study it significantly reduced casual sebum level after 6 weeks.

    Human trial · 2006 · 100 people · Japanese subjects plus 30 Caucasian subjects · Adults with facial sebum concerns applying a 2% niacinamide moisturiser for 2 to 6 weeks; measured with sebumeter-based sebum excretion rate and casual sebum level. · The effect differs by measured endpoint and population.

    PMID 16766489